Group 1 - The core viewpoint of the article highlights that Kangtong Medical's stock closed at 18.12 yuan, with a PE ratio of 27.74 times, and a total market capitalization of 1.812 billion yuan [1] - The average PE ratio for the medical device industry is 45.71 times, with a median of 29.99 times, placing Kangtong Medical at the 68th position in the industry ranking [1] - As of March 31, 2025, Kangtong Medical had 8,455 shareholders, a decrease of 143 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - In the latest quarterly report for Q3 2024, the company reported revenue of 492 million yuan, a year-on-year increase of 13.40%, while net profit was 20.0463 million yuan, reflecting a year-on-year decrease of 46.99%, with a gross profit margin of 20.02% [2] - The company specializes in the research, design, manufacturing, integration, and operation services of medical gas equipment and systems, including various medical gas supply systems and clean equipment [1] - Kangtong Medical has obtained 25 medical device registration certificates or filing documents and was the first company in China to pass the National Medical Products Administration's review for medical carbon dioxide excipients [1]
港通医疗收盘上涨1.23%，滚动市盈率27.74倍，总市值18.12亿元